Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:July 31, 2012Withdrawn
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:July 31, 2012Withdrawn
Condition(s):Essential HypertensionLast Updated:February 1, 2023Active, not recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:June 15, 2023Not yet recruiting
Condition(s):Osteoarthritis of Multiple Joints of Ankle or Foot; HealthyLast Updated:November 29, 2022Recruiting
Condition(s):Breast Cancer; HER2-negative Breast Cancer; Metastatic Breast CancerLast Updated:February 14, 2024Recruiting
Condition(s):Male Breast Cancer; Recurrent Melanoma; Stage IV Breast Cancer; Stage IV Melanoma; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Hepatocellular CarcinomaLast Updated:December 6, 2022Completed
Condition(s):Cardiometabolic Health; Healthy Aging; CognitionLast Updated:December 14, 2023Active, not recruiting
Condition(s):Type 2 Diabetes With Renal ManifestationsLast Updated:August 19, 2019Unknown status
Condition(s):Diastolic DysfunctionLast Updated:November 30, 2023Active, not recruiting
Condition(s):Obesity; Vascular DysfunctionLast Updated:May 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.